Clinical trial of MBX 1416 for Post-Bariatric Hypoglycemia begins
The first participant has been dosed in MBX Biosciences’ Phase 1/2 clinical trial of MBX 1416, the company’s long-acting glucagon-like...
top of page
Browse by category
Search
Phase III studies to investigate survodutide for people living with obesity and overweight
Boehringer Ingelheim and Zealand Pharma have initiated three Phase III trials investigating survodutide (also known as BI 456906) for...
First patient treated with SiPore21 for sustained diabetes and obesity control
The first patient has been treated with Sigrid Therapeutics’ SiPore21, an innovative medical device designed for sustained diabetes and...
Study links GLP-1s with serious gastrointestinal conditions
Glucagon-like peptide-1 (GLP-1) agonists are associated with an increased risk of serious medical conditions including stomach paralysis,...
T2DM diagnosis at age 30 can reduce life expectancy by up to 14 years
An individual diagnosed with type 2 diabetes at age 30 years could see their life expectancy fall by as much as 14 years, an...
Worldwide audit finds testosterone replacement improves glycaemic control in men for up to two years
Real-world data from an ongoing international audit of testosterone deficiency in men with type 2 diabetes, suggests that testosterone...
ASMBS appoints Diane Enos as new Executive Director
The American Society for Metabolic and Bariatric Surgery (ASMBS), the nation’s largest professional organisation of bariatric and...
Rejuva GLP-1-based pancreatic gene therapy candidate results in greater weight loss vs. semaglutide
Fractyl Health has revealed preclinical findings from its Rejuva gene therapy platform at the European Association for the Study of...
Journal Watch 4/10/2023
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Researchers find target for prompting fat cells to expend energy
Researchers at the University of Colorado School of Medicine have identified a potential target for treating obesity and metabolic...
Browse by tag
bottom of page